(Q37712177)

English

The lost hope of elimination of Kala-azar (visceral leishmaniasis) by 2010 and cyclic occurrence of its outbreak in India, blame falls on vector control practices or co-infection with human immunodeficiency virus or therapeutic modalities?

scientific article published on January 2014

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

22 August 2017

The lost hope of elimination of Kala-azar (visceral leishmaniasis) by 2010 and cyclic occurrence of its outbreak in India, blame falls on vector control practices or co-infection with human immunodeficiency virus or therapeutic modalities? (English)

1 reference

Europe PubMed Central

PMC publication ID

22 August 2017

vector-borne disease

0 references

0 references

visceral leishmaniasis

1 reference

based on heuristic

inferred from title

author name string

Mayilsamy Muniaraj

1

1 reference

Europe PubMed Central

PMC publication ID

22 August 2017

publication date

1 January 2014

1 reference

Europe PubMed Central

PMC publication ID

22 August 2017

Tropical Parasitology

1 reference

Europe PubMed Central

PMC publication ID

22 August 2017

4

1 reference

Europe PubMed Central

PMC publication ID

22 August 2017

1

1 reference

Europe PubMed Central

PMC publication ID

22 August 2017

10-19

1 reference

Europe PubMed Central

PMC publication ID

22 August 2017

Leishmania donovani develops resistance to drug combinations

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3992795

23 August 2017

Phase 4 pharmacovigilance trial of paromomycin injection for the treatment of visceral leishmaniasis in India

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3992795

23 August 2017

Insecticide susceptibility of Phlebotomus argentipes in visceral leishmaniasis endemic districts in India and Nepal

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3992795

23 August 2017

Effectiveness and Safety of Liposomal Amphotericin B for Visceral Leishmaniasis under Routine Program Conditions in Bihar, India

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3992795

23 August 2017

Treatment of visceral leishmaniasis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3992795

23 August 2017

Combination therapy for visceral leishmaniasis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3992795

23 August 2017

Can visceral leishmaniasis be eliminated from Asia?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3992795

23 August 2017

The relationship between leishmaniasis and AIDS: the second 10 years

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3992795

23 August 2017

Visceral leishmaniasis: what are the needs for diagnosis, treatment and control?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3992795

23 August 2017

Injectable paromomycin for Visceral leishmaniasis in India

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3992795

23 August 2017

Vector control in leishmaniasis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3992795

23 August 2017

Drug unresponsiveness & combination therapy for kala-azar

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3992795

23 August 2017

Visceral leishmaniasis (kala-azar): challenges ahead

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3992795

23 August 2017

Laboratory diagnosis of visceral leishmaniasis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3992795

23 August 2017

Visceral leishmaniasis: current status of control, diagnosis, and treatment, and a proposed research and development agenda

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3992795

23 August 2017

Failure of pentavalent antimony in visceral leishmaniasis in India: report from the center of the Indian epidemic

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3992795

23 August 2017

Epidemiology of visceral leishmaniasis in India

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3992795

23 August 2017

Efficacy and safety of liposomal amphotericin B (AmBisome) for visceral leishmaniasis in endemic developing countries.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3992795

23 August 2017

Randomised controlled trial of aminosidine (paromomycin) v sodium stibogluconate for treating visceral leishmaniasis in North Bihar, India

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3992795

23 August 2017

Comparison of regimens of treatment with sodium stibogluconate in kala-azar

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3992795

23 August 2017

Transmission dynamics and underreporting of Kala-azar in the Indian state of Bihar

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3992795

6 September 2017

Leishmaniasis and poverty

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3992795

6 September 2017

Drug resistance in Indian visceral leishmaniasis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3992795

6 September 2017

Human leishmaniasis: clinical, diagnostic, and chemotherapeutic developments in the last 10 years

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3992795

6 September 2017

Visceral leishmaniasis/human immunodeficiency virus co-infection in India: the focus of two epidemics.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3992795

14 September 2017

Serious underreporting of visceral leishmaniasis through passive case reporting in Bihar, India.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3992795

14 September 2017

Amphotericin B in resistant kala-azar in Bihar

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3992795

28 September 2017

Unusual case of resistance to amphotericin B in visceral leishmaniasis in a region in India where leishmaniasis is not endemic

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3992795

23 June 2018

Vector density and the control of kala-azar in Bihar, India

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3992795

23 June 2018

Evaluation of diamidine compound (pentamidine isethionate) in the treatment resistant cases of kala-azar occurring in North Bihar, India

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3992795

23 June 2018

Liposomal amphotericin B for visceral leishmaniasis in human immunodeficiency virus-coinfected patients: 2-year treatment outcomes in Bihar, India

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3992795

1 September 2018

A report on the indoor residual spraying (IRS) in the control of Phlebotomus argentipes, the vector of visceral leishmaniasis in Bihar (India): an initiative towards total elimination targeting 2015 (Series-1).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3992795

1 September 2018

Newer strategies for the kala-azar elimination programme in India

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3992795

1 September 2018

A new strategy for elimination of kala-azar from rural Bihar.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3992795

1 September 2018

Resistance of sandflies to DDT in Kala-azar endemic districts of Bihar, India

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3992795

1 September 2018

A prospective randomized, comparative, open-label trial of the safety and efficacy of paromomycin (aminosidine) plus sodium stibogluconate versus sodium stibogluconate alone for the treatment of visceral leishmaniasis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3992795

1 September 2018

Control of the leishmaniases. Report of a WHO Expert Committee

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3992795

2 October 2018

Visceral Leishmaniasis and HIV Coinfection in Bihar, India

1 reference

https://pubmed.ncbi.nlm.nih.gov/24754021

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy of miltefosine in the treatment of visceral leishmaniasis in India after a decade of use

1 reference

https://pubmed.ncbi.nlm.nih.gov/24754021

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The leishmaniases. Report of a WHO Expert Committee

1 reference

https://pubmed.ncbi.nlm.nih.gov/24754021

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A cluster of cases of severe cardiotoxicity among kala-azar patients treated with a high-osmolarity lot of sodium antimony gluconate

1 reference

https://pubmed.ncbi.nlm.nih.gov/24754021

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Occurrence & significance of kala-azar in Bhutan

1 reference

https://pubmed.ncbi.nlm.nih.gov/24754021

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Kala-Azar (visceral leishmaniasis) and HIV coinfection in Bihar, India: is this combination increasing?

1 reference

https://pubmed.ncbi.nlm.nih.gov/24754021

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The treatment of kala-azar--new approaches to an old problem

1 reference

https://pubmed.ncbi.nlm.nih.gov/24754021

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical profile of cases of kala-azar in Bihar

1 reference

https://pubmed.ncbi.nlm.nih.gov/24754021

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Elimination of leishmaniasis (kala-azar) from the Indian subcontinent is technically feasible & operationally achievable

1 reference

https://pubmed.ncbi.nlm.nih.gov/24754021

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of short-course multidrug treatment with standard therapy for visceral leishmaniasis in India: an open-label, non-inferiority, randomised controlled trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/24754021

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A new focus of visceral leishmaniasis in sub-Himalayan (Kumaon) region of northern India

1 reference

https://pubmed.ncbi.nlm.nih.gov/24754021

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Evaluation of efficacy of longer durations of therapy of fresh cases of kala-azar with sodium stibogluconate

1 reference

https://pubmed.ncbi.nlm.nih.gov/24754021

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The treatment of visceral leishmaniasis (kala-azar) in India: no obvious signs of long-term success

1 reference

https://pubmed.ncbi.nlm.nih.gov/24754021

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.4103/2229-5070.129143

1 reference

Europe PubMed Central

PMC publication ID

22 August 2017

release_5jsvmm5zvjc4vdqz36n6ex3mre

1 reference

https://api.fatcat.wiki/v0/release/5jsvmm5zvjc4vdqz36n6ex3mre

24 November 2022

based on heuristic

mapped directly with Wikidata item

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

22 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

22 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37712177&oldid=2175845698"